Published: June 19th 2024 | Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: January 20th 2025 | Updated: February 12th 2025
The Present and Future of M&A: Q&A with Subin Baral
Published: January 14th 2025 | Updated: February 12th 2025
Teva Agrees to Strategic Partnerships with Formycon AG, Klinge Biopharma, & Samsung Bioepis
Published: January 27th 2025 | Updated: February 12th 2025
Exploring Biopharma's Dealmaking Terrain, Roadmap in China
Published: January 22nd 2025 | Updated: February 12th 2025
Sen-Jam Partners Strikes Deal with 5 Horizons Capital to Support Phase II Trial of SJP-001 for Inflammation, Metabolic Health
Published: January 30th 2025 | Updated: February 12th 2025
ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer